Recursion Pharmaceuticals
RXRX
$8.28
Share price
-6.65%
Change (1 day)
-5.59%
Change (1 year)
Categories
P/S ratio for Recursion Pharmaceuticals (RXRX)
P/S ratio as of June 2024 (TTM): 45.2
According to Recursion Pharmaceuticals's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 45.1558. At the end of 2023 the company had a P/S ratio of 48.5.
P/S ratio history for Recursion Pharmaceuticals from 2021 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 48.5 | 31.72% |
| 2022 | 36.8 | -87.28% |
| 2021 | 289 |